openPR Logo
Press release

Benign Prostatic Hypertrophy Implant Devices Market Trade Analysis and Growth Predictions (2024-2031) - Olympus Corporation, Boston Scientific Corporation, Medifocus Inc.

10-22-2024 01:47 PM CET | Health & Medicine

Press release from: DataM Intelligence 4market Research LLP

Benign Prostatic Hypertrophy Implant Devices Market

Benign Prostatic Hypertrophy Implant Devices Market

The Benign Prostatic Hypertrophy Implant Devices Market study by DataM Intelligence offer an in-depth analysis of the market, presenting insightful observations, statistics, historical data, and industry-validated market insights. The report delves into the competitive positioning of key companies, examining factors such as product offerings, pricing strategies, financial health, product portfolios, growth initiatives, and geographical reach.

Get a Free Sample PDF - https://datamintelligence.com/download-sample/benign-prostatic-hypertrophy-implant-devices-market

The Benign Prostatic Hypertrophy Implant Devices Market is estimated to reach at a significant CAGR 6.7% during the forecast period 2024-2031.

Benign prostatic hypertrophy (BPH) implant devices are medical interventions designed to alleviate symptoms associated with an enlarged prostate. These devices, such as the UroLift System and Rezūm System, are minimally invasive and aim to reduce urinary obstruction caused by BPH. The UroLift System involves the placement of small implants that lift and hold the enlarged prostate tissue out of the way, while the Rezūm System utilizes steam to ablate excess tissue. Both options offer benefits such as rapid recovery and reduced risk compared to traditional surgical methods. As the prevalence of BPH increases with age, the demand for these innovative implant devices is expected to grow, offering patients effective symptom relief and improved quality of life .

Key Players

The companies are primarily focusing on strategies such as new product launches to penetrate the fastest-growing emerging markets across the world. The prominent players in Benign Prostatic Hypertrophy Implant Devices market research report are:

Olympus Corporation, Boston Scientific Corporation, Medifocus Inc., KARL STORZ SE & Co. KG, NxThera, Inc., ProArc Medical, Lisa Laser Products OHG, Richard Wolf Gmbh, Guangzhou Maya Medical Equipment.Co.ltd and Guangzhou Medunion Technologies Co.ltd.

Key Development

On April 6, 2020, Olympus announced the FDA de Novo classification of the iTind device, marking a significant advancement in the treatment of Benign Prostatic Hyperplasia (BPH). This non-surgical, minimally invasive device was developed by Medi-Tate, an Israeli medical device manufacturer, and is designed to relieve urinary symptoms associated with BPH without the need for traditional surgery. Olympus has secured exclusive rights to distribute the iTind device in the U.S. through its investment in Medi-Tate. The iTind device works by temporarily implanting a flexible nitinol device that gently expands the prostate tissue, thereby reducing obstruction in the urethra. This innovative approach aims to improve patient comfort and recovery time, reflecting a growing trend towards less invasive treatment options in urology .

Regions Covered:

The global Benign Prostatic Hypertrophy Implant Devices Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.

☞ North America - US, Canada, Mexico

☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe

☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific

☞ South America- Brazil, Argentina, Colombia, Rest of South America

☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel

Get this Premium Report: https://www.datamintelligence.com/buy-now-page?report=benign-prostatic-hypertrophy-implant-devices-market

Market Segments

By Product Type: Prostatic Urethral Lift, Transurethral Resection of the Prostate (TURP), Prostatectomy, Laser Surgery, Transurethral Microwave Therapy (TUMT), Others.

By End-User: Hospitals, Ambulatory Surgery Centers.

The Benign Prostatic Hypertrophy Implant Devices industry is experiencing rapid growth, driven by advancements in medical technologies, increased demand for innovative therapies, and a rising focus on patient-centered care. As these sectors evolve, the need for comprehensive market analysis becomes crucial to understand trends, regulatory changes, and emerging opportunities.

Key Features

Leverage epidemiology insights to tailor precision diagnostics and address region-specific needs.

Meet critical unmet needs in complex conditions with advanced, precise Benign Prostatic Hypertrophy Implant Devices industry solutions for better diagnostics and outcomes.

Stay ahead with real-time pipeline analysis, revealing the latest Benign Prostatic Hypertrophy Implant Devices innovations and market trends.

Optimize your offerings with competitive pricing analysis, balancing cost-effectiveness and cutting-edge tech.

Protect your innovation with expert patent analysis, ensuring strategic positioning in the Benign Prostatic Hypertrophy Implant Devices market.

Gain an edge with comprehensive competitive intelligence, guiding informed decisions in Benign Prostatic Hypertrophy Implant Devices

Maximize market presence with brand share analysis, strengthening your position in the Benign Prostatic Hypertrophy Implant Devices landscape.

Accurately predict market demand for Benign Prostatic Hypertrophy Implant Devices with precise drug sales forecasting insights.

Get Customization in the report as per your requierments: https://datamintelligence.com/customize/benign-prostatic-hypertrophy-implant-devices-market

FAQs

Which region is expected to have the highest market Share during the forecast period?

North America is expected to have the highest market share during the forecast period due to high incidence rate of the geriatric population in this region and advancements in the healthcare technology.

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Benign Prostatic Hypertrophy Implant Devices Market Trade Analysis and Growth Predictions (2024-2031) - Olympus Corporation, Boston Scientific Corporation, Medifocus Inc. here

News-ID: 3704585 • Views:

More Releases from DataM Intelligence 4market Research LLP

United States Fortified Organic Fertilizers Market Trends: Biofertilizer Blends, Slow-Release Formulations, and Micronutrient Enrichment Driving Adoption
United States Fortified Organic Fertilizers Market Trends: Biofertilizer Blends, …
Global Fortified Organic Fertilizers Market reached US$ 1.92 billion in 2022 and is expected to reach US$ 2.68 billion by 2031, growing with a CAGR of 4.2% during the forecast period 2024-2031. The fortified organic fertilizers market includes natural fertilizers enhanced with nutrients like nitrogen, phosphorus, potassium, and micronutrients to improve soil fertility and crop yield. These fertilizers promote sustainable agriculture by reducing chemical dependency and enhancing soil health. Market growth
United States Multiplexed Diagnostics Market Share, Trends, Top Players, Segments and Forecasts Research-Luminex Corporation, Thermo Fisher Scientific, Bio-Rad Laboratories, Inc
United States Multiplexed Diagnostics Market Share, Trends, Top Players, Segment …
The Multiplexed Diagnostics Market is estimated to reach at a Significant CAGR during the forecast period (2024-2031). The multiplexed diagnostics market includes tests that simultaneously detect multiple biomarkers or pathogens from a single sample. These diagnostics improve efficiency, reduce costs, and enable faster decision-making in clinical practice. Applications span infectious diseases, oncology, autoimmune disorders, and genetic testing. Market growth is driven by rising demand for personalized medicine and point-of-care testing. Advances
United States Plant Breeding and CRISPR Plant Market Outlook 2024-2031: Innovations in Genome Editing, Crop Yield, and Sustainable Agriculture | Bayer AG, BASF, Syngenta Crop Protection AG.
United States Plant Breeding and CRISPR Plant Market Outlook 2024-2031: Innovati …
Plant Breeding and CRISPR Plant Market is forecasted to reach at a CAGR of 10.87% during the forecast period (2024-2031). This market focuses on improving crop yield, quality, and resistance through modern breeding techniques and CRISPR-based genome editing. Plant breeding innovations support food security by developing climate-resilient and pest-resistant varieties. CRISPR technology enables precise genetic modifications, reducing time compared to conventional breeding. Market growth is driven by increasing global food demand
Recent Developments in Neuromorphic Computing: Intel, IBM, Qualcomm, Fujitsu, Sony, and Global Research Institutions Driving Innovation
Recent Developments in Neuromorphic Computing: Intel, IBM, Qualcomm, Fujitsu, So …
The Global Neuromorphic Computing Market reached USD 48.3 million in 2022 and is projected to witness lucrative growth by reaching up to USD 6,801.9 million by 2030. The global neuromorphic computing market is expected to exhibit a CAGR of 91.5% during the forecast period (2024-2031). The neuromorphic computing market revolves around hardware and systems modeled on the human brain's neural architecture, enabling advanced processing and learning capabilities. These systems aim to

All 5 Releases


More Releases for Benign

Rising Geriatric Population Drives Growth Of Benign Prostatic Hypertrophy Drugs …
The Drugs For Benign Prostatic hypertrophy Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Projected Growth of the Drugs For Benign Prostatic hypertrophy Market? The drugs for benign prostatic hypertrophy market has shown strong growth, expanding from $4.28 billion in 2024 to $4.58
Prominent Drugs For Benign Prostatic hypertrophy Market Trend for 2025: Innovati …
What Are the Projected Growth and Market Size Trends for the Drugs For Benign Prostatic hypertrophy Market? The market size for benign prostatic hypertrophy medication has seen considerable growth in recent years. It is projected to increase from $4.28 billion in 2024 to $4.58 billion in 2025, with a compound annual growth rate (CAGR) of 6.8%. The significant growth during the historic period can be linked to an aging population, heightened
Shaping the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment M …
How Big Is the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Expected to Be, and What Will Its Growth Rate Be? In recent times, there has been robust growth in the market size of benign prostatic hyperplasia (BPH) treatment devices and equipment. The market, which stood at $1.29 billion in 2024, is anticipated to increase to $1.38 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.2%.
Prominent Drugs For Benign Prostatic hypertrophy Market Trend for 2025: Innovati …
What Are the Projected Growth and Market Size Trends for the Drugs For Benign Prostatic hypertrophy Market? The market size for benign prostatic hypertrophy medication has seen considerable growth in recent years. It is projected to increase from $4.28 billion in 2024 to $4.58 billion in 2025, with a compound annual growth rate (CAGR) of 6.8%. The significant growth during the historic period can be linked to an aging population, heightened
Prominent Drugs For Benign Prostatic hypertrophy Market Trend for 2025: Innovati …
What Are the Projected Growth and Market Size Trends for the Drugs For Benign Prostatic hypertrophy Market? The market size for benign prostatic hypertrophy medication has seen considerable growth in recent years. It is projected to increase from $4.28 billion in 2024 to $4.58 billion in 2025, with a compound annual growth rate (CAGR) of 6.8%. The significant growth during the historic period can be linked to an aging population, heightened
Shaping the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment M …
How Big Is the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Expected to Be, and What Will Its Growth Rate Be? In recent times, there has been robust growth in the market size of benign prostatic hyperplasia (BPH) treatment devices and equipment. The market, which stood at $1.29 billion in 2024, is anticipated to increase to $1.38 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.2%.